Appco Pharma LLC is recalling 1,380 bottles of Venlafaxine Extended-Release Tablets (150 mg), a prescription medication used to treat depression and anxiety. The recall was issued because some tablets may be missing the required identification mark on either side of the pill. If you have health concerns regarding this medication, please contact your healthcare provider or pharmacist.
Missing identification marks on tablets can lead to medication errors if a patient or caregiver cannot verify that the correct pill is being taken, especially when multiple medications are managed together.
You have 2 options:
Missing tab ID on either side of the tablet.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.